Eagle Pharmaceuticals, Inc.

FMR LLC EGRX

Report date

9/30/2024

Quarter

2024 Q3

Filed

11/13/2024

Shares

28,348

Value ($000)

106

Weight

0.0%

2019 Q4 - 2024 Q3 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q3	11/13/2024	106	0.0%	28,348	9/30/2024
2024 Q2	8/13/2024	163	0.0%	29,163	6/30/2024
2024 Q1	5/13/2024	116	0.0%	22,103	3/31/2024
2023 Q4	2/13/2024	108	0.0%	20,717	12/31/2023
2023 Q3	11/13/2023	300	0.0%	19,032	9/30/2023
2023 Q2	8/11/2023	382	0.0%	19,634	6/30/2023
2023 Q1	5/11/2023	17	0.0%	586	3/31/2023
2022 Q4	2/13/2023	6	0.0%	208	12/31/2022
2022 Q3	11/10/2022	340	0.0%	12,901	9/30/2022
2022 Q2	8/12/2022	1,505	0.0%	33,880	6/30/2022
2022 Q1	5/13/2022	641	0.0%	12,953	3/31/2022
2021 Q4	2/14/2022	5	0.0%	100	12/31/2021
2021 Q3	2/14/2022	6	0.0%	107	9/30/2021
2021 Q2	8/13/2021	7	0.0%	179	6/30/2021
2021 Q1	5/14/2021	6	0.0%	150	3/31/2021
2020 Q4	2/8/2021	5	0.0%	100	12/31/2020
2020 Q3	11/13/2020	4	0.0%	100	9/30/2020
2020 Q2	8/24/2020	5	0.0%	100	6/30/2020
2020 Q1	5/14/2020	2,226	0.0%	48,390	3/31/2020
2019 Q4	2/7/2020	2,896	0.0%	48,208	12/31/2019